Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNexxen Int Ltd Regulatory News (NEXN)

Share Price Information for Nexxen Int Ltd (NEXN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 248.50
Bid: 248.50
Ask: 258.00
Change: -5.50 (-2.17%)
Spread: 9.50 (3.823%)
Open: 257.00
High: 257.00
Low: 247.50
Prev. Close: 248.50
NEXN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Block Listing Application

2 Apr 2024 11:30

RNS Number : 9711I
Nexxen International Ltd
02 April 2024
 

2 April 2024

 

Nexxen International Ltd

("Nexxen" or the "Company")

Block Listing Application

Nexxen International Ltd. (AIM/NASDAQ: NEXN) ("Nexxen" or the "Company"), a global, unified advertising technology platform with deep expertise in video and Connected TV ("CTV"), announces that application has been made to the London Stock Exchange plc for a block admission of 4,000,000 ordinary shares of NIS0.01 each in the capital of the Company ("New Ordinary Shares") to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur on or around the 8 April 2024.

These New Ordinary Shares shall be issued and allotted from time to time pursuant to the exercise of share options and the vesting of restricted share units (RSUs), performance share units (PSUs) and restricted shares under the Company's Global Share Incentive Plan (2011), the Company's 2017 Equity Incentive Plan and the New Taptica Management Incentive Scheme and RhythmOne Plan (2019). The New Ordinary Shares, when issued, shall rank equally with the Company's existing issued ordinary shares.

 

For further information please contact:

 

Nexxen International Ltd.

Billy Eckert, Vice President of Investor Relations

ir@nexxen.com

 

Caroline Smith, Vice President of Communications

csmith@nexxen.com

 

KCSA (U.S. Investor Relations)David Hanover, Investor Relationsnexxenir@kcsa.com

 

Vigo Consulting (U.K. Financial PR & Investor Relations)Jeremy GarciaPeter Jacob

Aisling FitzgeraldTel: +44 20 7390 0230 or nexxen@vigoconsulting.com

 

Cavendish Capital Markets LimitedJonny Franklin-Adams / Charlie Beeson / George Dollemore (Corporate Finance)Tim Redfern / Harriet Ward (ECM)Tel: +44 20 7220 0500

 

About Nexxen International

Nexxen International empowers advertisers, agencies, publishers and broadcasters around the world to utilize video and Connected TV in the ways that are most meaningful to them. Comprised of a demand-side platform (DSP), supply-side platform (SSP), ad server and data management platform (DMP), Nexxen delivers a flexible and unified technology stack with advanced and exclusive data at its core. Our robust capabilities span discovery, planning, activation, measurement, and optimization - available individually or in combination - all designed to enable our partners to reach their goals, no matter how far-reaching or hyper niche they may be. For more information, visit nexxen.com.

Nexxen is headquartered in Israel and maintains offices throughout the United States, Canada, Europe, and Asia-Pacific, and is traded on the London Stock Exchange (AIM: NEXN) and NASDAQ (NEXN).

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSBGGDSCDGDGSD
Date   Source Headline
3rd Apr 20247:00 amRNSShare buyback-transaction in own shares
2nd Apr 202411:30 amRNSBlock Listing Application
2nd Apr 20247:00 amRNSTotal Voting Rights
28th Mar 20241:40 pmRNSHolding(s) in Company
28th Mar 20247:00 amRNSShare buyback-transaction in own shares
27th Mar 20247:00 amRNSShare buyback-transaction in own shares
26th Mar 202411:05 amRNSDirector Dealings
25th Mar 20247:00 amRNSShare buyback-transaction in own shares
22nd Mar 20247:00 amRNSShare buyback-transaction in own shares
21st Mar 20247:00 amRNSShare buyback-transaction in own shares
19th Mar 20247:00 amRNSShare buyback-transaction in own shares
18th Mar 20247:00 amRNSShare buyback-transaction in own shares
15th Mar 20247:01 amRNSShare buyback-transaction in own shares
15th Mar 20247:00 amRNS$50 Million Ordinary Share Repurchase Program
14th Mar 20247:00 amRNSShare buyback-transaction in own shares
13th Mar 20247:00 amRNSShare buyback-transaction in own shares
12th Mar 20247:00 amRNSShare buyback-transaction in own shares
11th Mar 20247:00 amRNSShare buyback-transaction in own shares
8th Mar 20247:00 amRNSShare buyback-transaction in own shares
7th Mar 20247:00 amRNSShare buyback-transaction in own shares
6th Mar 20247:01 amRNSShare buyback-transaction in own shares
6th Mar 20247:00 amRNSQ4 and FY2023 Results
5th Mar 20247:00 amRNSShare buyback-transaction in own shares
4th Mar 20247:00 amRNSShare buyback-transaction in own shares
1st Mar 20247:15 amRNSTotal Voting Rights
1st Mar 20247:00 amRNSShare buyback-transaction in own shares
29th Feb 20247:00 amRNSShare buyback-transaction in own shares
28th Feb 20247:01 amRNSShare buyback-transaction in own shares
28th Feb 20247:00 amRNSAlphonso Inc Settlement Agreement & Partnership
27th Feb 20247:01 amRNSShare buyback-transaction in own shares
27th Feb 20247:00 amRNSQ4 2023 Results Conference Call Details
26th Feb 20247:00 amRNSShare buyback-transaction in own shares
23rd Feb 20247:00 amRNSShare buyback-transaction in own shares
22nd Feb 20247:00 amRNSShare buyback-transaction in own shares
21st Feb 20247:00 amRNSShare buyback-transaction in own shares
20th Feb 20247:29 amRNSShare buyback-transaction in own shares
19th Feb 20247:00 amRNSShare buyback-transaction in own shares
16th Feb 20247:00 amRNSShare buyback-transaction in own shares
15th Feb 20242:00 pmRNSNexxen and PeerLogix Launch Exclusive Partnership
15th Feb 20247:00 amRNSShare buyback-transaction in own shares
14th Feb 20247:00 amRNSShare buyback-transaction in own shares
13th Feb 20247:00 amRNSShare buyback-transaction in own shares
9th Feb 20247:00 amRNSShare buyback-transaction in own shares
8th Feb 20242:00 pmRNSNexxen and TCL FFALCON Expand Partnership
8th Feb 20247:00 amRNSShare buyback-transaction in own shares
7th Feb 202410:19 amRNSHolding(s) in Company
7th Feb 20247:00 amRNSShare buyback-transaction in own shares
6th Feb 20248:54 amRNSShare buyback - Replacement
6th Feb 20247:00 amRNSShare buyback-transaction in own shares
5th Feb 20247:00 amRNSShare buyback-transaction in own shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.